Results 171 to 180 of about 972,269 (340)
Comparison of probability of stroke between the Copenhagen City Heart Study and the Framingham Study. [PDF]
Thomas Truelsen +2 more
openalex +1 more source
Metabolic syndrome and atrial cardiomyopathy each show a positive but statistically non‐significant association with stroke mortality, but their coexistence confers a synergistically higher risk. ABSTRACT Introduction Metabolic syndrome (MetS) and atrial cardiomyopathy (AtCM) are recognized as risk factors for cardiovascular disease, including stroke ...
Yaodongqin Xia +3 more
wiley +1 more source
Arterial Stiffness and Cardiovascular Events: The Framingham Heart Study
G. Mitchell +8 more
semanticscholar +1 more source
Implications of inflammation and sex in lower extremity arterial disease
The graphical abstract illustrates the role of inflammation and sex‐related differences in lower extremity artery disease (LEAD). Key inflammatory biomarkers associated with LEAD include C‐reactive protein (CRP), fibrinogen, interleukin‐6 (IL‐6), and D‐dimer, which contribute to vascular inflammation and atherosclerotic plaque formation in lower limb ...
Katja Schnidrig +7 more
wiley +1 more source
Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study
D. Lloyd‐Jones +10 more
semanticscholar +1 more source
Heritability of Age at Natural Menopause in the Framingham Heart Study [PDF]
Joanne M. Murabito +4 more
openalex +1 more source
Framingham Heart Study: An Enduring Legacy
Wong, Nathan D. +2 more
openaire +3 more sources
The Framingham Heart Study: past, present and future [PDF]
Connie W, Tsao, Ramachandran S, Vasan
openaire +2 more sources
This study shows that overweight and obese patients with atrial fibrillation experience improved outcomes when treated with DOACs compared with VKAs. Specifically, DOAC use was associated with lower risks of all‐cause mortality and cardiovascular events.
Danilo Menichelli +58 more
wiley +1 more source

